Ambev S.A. (NYSE:ABEV - Get Free Report) has earned an average recommendation of "Reduce" from the five brokerages that are covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation and four have issued a hold recommendation on the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $2.60.
Several analysts recently issued reports on ABEV shares. Wall Street Zen initiated coverage on shares of Ambev in a research note on Wednesday, April 23rd. They set a "buy" rating for the company. Morgan Stanley cut shares of Ambev from an "equal weight" rating to an "underweight" rating in a research note on Monday, April 7th. Barclays increased their price target on shares of Ambev from $2.00 to $2.50 and gave the company an "equal weight" rating in a research note on Monday, May 12th. Finally, UBS Group upped their price objective on shares of Ambev from $2.60 to $2.70 and gave the stock a "neutral" rating in a report on Wednesday, June 4th.
View Our Latest Stock Analysis on Ambev
Institutional Investors Weigh In On Ambev
A number of hedge funds have recently added to or reduced their stakes in ABEV. Abacus Wealth Partners LLC acquired a new stake in shares of Ambev in the 2nd quarter valued at $25,000. GAMMA Investing LLC raised its holdings in shares of Ambev by 468.4% in the 1st quarter. GAMMA Investing LLC now owns 10,998 shares of the company's stock valued at $26,000 after purchasing an additional 9,063 shares in the last quarter. Integrated Wealth Concepts LLC acquired a new stake in shares of Ambev in the 1st quarter valued at $26,000. Perigon Wealth Management LLC acquired a new stake in shares of Ambev in the 1st quarter valued at $27,000. Finally, Generation Capital Management LLC acquired a new stake in shares of Ambev in the 4th quarter valued at $28,000. 8.13% of the stock is currently owned by institutional investors and hedge funds.
Ambev Stock Down 0.2%
ABEV stock traded down $0.01 during trading on Wednesday, hitting $2.38. 2,560,049 shares of the company's stock traded hands, compared to its average volume of 31,003,078. The firm has a market capitalization of $37.42 billion, a P/E ratio of 14.84, a PEG ratio of 2.57 and a beta of 0.74. The business has a fifty day simple moving average of $2.45 and a two-hundred day simple moving average of $2.23. The company has a quick ratio of 0.80, a current ratio of 1.11 and a debt-to-equity ratio of 0.02. Ambev has a 1 year low of $1.76 and a 1 year high of $2.64.
Ambev (NYSE:ABEV - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The company reported $0.04 EPS for the quarter, hitting the consensus estimate of $0.04. The business had revenue of $3.92 billion during the quarter, compared to the consensus estimate of $22.40 billion. Ambev had a net margin of 15.76% and a return on equity of 14.74%. Sell-side analysts anticipate that Ambev will post 0.18 EPS for the current year.
Ambev Cuts Dividend
The firm also recently announced a -- dividend, which was paid on Thursday, July 17th. Shareholders of record on Monday, May 19th were issued a dividend of $0.0219 per share. The ex-dividend date of this dividend was Monday, May 19th. This represents a yield of 5%. Ambev's dividend payout ratio (DPR) is presently 68.75%.
About Ambev
(
Get Free ReportAmbev SA, through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, malt and food, other alcoholic beverages, and non-alcoholic and non-carbonated products in Brazil, Central America and Caribbean, Latin America South, and Canada. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Budweiser, Bud Light, Beck, Leffe, Hoegaarden, Balboa ICE, Balboa, Atlas Golden Light, Atlas, Bucanero, Cristal, Mayabe, Presidente, Presidente Light, Brahma Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Bud 66, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith's, and Kokanee brands.
Read More

Before you consider Ambev, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ambev wasn't on the list.
While Ambev currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.